Pharmafile Logo

Another spellbinding result for Lucid Group at the 2018 PMEAs

November 23, 2018 |  

- PMLiVE
Lucid’s pioneering approach to medical education was clear to see as they scooped two top awards and a high commendation at last night’s awards ceremony.

The first award was gained in the category,
Excellence in Rare Diseases and Orphan Drugs’ for, Revolutionising Management of Hidradenitis Suppurativa in Europe: Why? What? How? This was coupled with a high commendation in the same category for, Advancing Science in a Rare Disease – A Cost Effective Clinical Decision Support Programme for Cystinosis.  

Lucid’s second big win of the night was being crowned PMEA Support Agency of the Year 2018, testament to the amazing client partnerships they have built over the last eleven years.

Jan Steele, Lucid COO and Co-founder commented, “I am delighted that the work of our teams and clients have been recognised. Our shared passion to make a difference and improve patients’ lives drives everything we do and underpins the magical programmes we create with our clients.” 

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid make the shortlist in all of the four categories they entered for the PMEA programme 2016

The PMEA programme rewards responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes. The awards have been specifically designed to recognise and commend excellence, best...

Lucid bolsters its senior leadership team

Lucid Group has had a successful summer attracting top talent to its senior leadership team with the appointment of Shula Sarner (Executive Scientific Director) and Tanya Goodyear (Division Director, Immunology).

IBD Oxford MasterClass 2016 harnesses the chemistry between science and clinical practice

Leading Edge, part of the Lucid Group, delivered another successful Oxford MasterClass this year, which attracted over 260 delegates and 60 international inflammatory bowel disease (IBD) faculty, representing Europe, Asia, Australasia...

Lucid Group becomes a sponsor of MedComms Networking

To help Lucid access the valuable medical communications professional network they have become a sponsor of MedComms Networking, headed by Peter Llewellyn. Jan Steele (Co-founder and COO of Lucid Group)...

Lucid launch new recruitment campaign to attract top talent in medical writing

We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from...

Knowing your audience is key to successful medical education

Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...

Making a difference together

It was highlighted at the 2016 World Economic Forum that ‘good business’ now means more than financial success, with multiple stakeholders asking how business will benefit society. At Lucid, our...

Lucid Group take time out for work and play at their annual Summer Meeting

Lucid Group may be an award-winning medical education agency, packed with industry-leading talent, but it still understands how important it is to provide the best customer experience possible. 2015 was an...

Louise Verrall from Lucid Group wins Communiqué 2016 Award for Emerging Leader in Healthcare Communications

From her first degree to her current position as Business Unit Director, Louise has developed a passion for science, education, psychology and entrepreneurialism. She is driven to make a difference...